Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Nadler · SciRah

Researcher profile · Semantic Scholar

E. Nadler

Share profile

E. Nadler — researcher profile on SciRah

h-index: 17
Works: 79
Citations: 1,335

Most-cited papers

Measuring patient-centered communication in cancer care: a literature review and the development of a systematic approach.
L. McCormack, K. Treiman, Douglas J. Rupert, Pamela A. Williams-Piehota +4 more
2011Social Science & Medicine (1967)357 citations Open access
Semantic Scholar
Do oncologists believe new cancer drugs offer good value?
E. Nadler, B. Eckert, P. Neumann
2005The Oncologist203 citations Open access
Semantic Scholar
Cancer therapy costs influence treatment: a national survey of oncologists.
P. Neumann, J. Palmer, E. Nadler, C. Fang +1 more
2010Health Affairs140 citations
Semantic Scholar
Surgical stress-induced immune cell redistribution profiles predict short-term and long-term postsurgical recovery. A prospective study.
P. Rosenberger, J. Ickovics, E. Epel, E. Nadler +4 more
2009Journal of Bone and Joint Surgery. American volume86 citations Open access
Semantic Scholar
Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs.
S. Berry, C. Bell, P. Ubel, W. Evans +3 more
2010Journal of Clinical Oncology71 citations Open access
Semantic Scholar
Treatment Patterns and Clinical Outcomes Among Metastatic Non–Small‐Cell Lung Cancer Patients Treated in the Community Practice Setting
E. Nadler, J. Espirito, M. Pavilack, M. Boyd +2 more
2018Clinical Lung Cancer46 citations Open access
Semantic Scholar
Treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer initiating first-line treatment in the US community oncology setting: a real-world retrospective observational study
E. Nadler, B. Arondekar, K. Aguilar, Jie Zhou +3 more
2020Journal of Cancer Research and Clinical Oncology38 citations Open access
Semantic Scholar
In A Survey, Marked Inconsistency In How Oncologists Judged Value Of High-Cost Cancer Drugs In Relation To Gains In Survival
P. Ubel, S. Berry, E. Nadler, C. Bell +5 more
2012Health Affairs31 citations Open access
Semantic Scholar
Bevacizumab treatment to progression after chemotherapy: outcomes from a U.S. community practice network.
E. Nadler, E. Yu, A. Ravelo, A. Sing +2 more
2011The Oncologist31 citations Open access
Semantic Scholar
Real-world patterns of biomarker testing and targeted therapy in de novo metastatic non-small cell lung cancer patients in the US oncology network.
E. Nadler, A. Vasudevan, Yunfei Wang, S. Ogale
2022Cancer Treatment and Research Communications25 citations Open access
Semantic Scholar
Epidemiology, Treatment Patterns, and Outcomes of Metastatic Soft Tissue Sarcoma in a Community-Based Oncology Network
Clara C. Chen, R. Borker, J. Ewing, Wan-Yu Tseng +4 more
2014Sarcoma25 citations Open access
Semantic Scholar
Safety and Efficacy of Pembrolizumab in Combination with Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study
M. Taylor, Courtney B. Betts, Lauren Maloney, E. Nadler +11 more
2021Clinical Cancer Research24 citations Open access
Semantic Scholar
Phase II data with ZD6474, a small-molecule kinase inhibitor of epidermal growth factor receptor and vascular endothelial growth factor receptor, in previously treated advanced non-small-cell lung cancer.
David J. Lee, R. Natale, E. Nadler, Vinay Jain
2005Clinical Lung Cancer24 citations
Semantic Scholar
Treatment patterns and outcomes in patients with non-squamous advanced non-small cell lung cancer receiving second-line treatment in a community-based oncology network.
I. Pan, R. Mallick, R. Dhanda, E. Nadler
2013Lung Cancer23 citations
Semantic Scholar
Observational Study of Treatment Patterns in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Non-Small Cell Lung Cancer After First-Line EGFR-Tyrosine Kinase Inhibitors
E. Nadler, M. Pavilack, J. Espirito, J. Clark +1 more
2020Advances in Therapy19 citations
Semantic Scholar
Does framing of cancer survival affect perceived value of care? A willingness-to-pay survey of US residents
Pei-Jung Lin, T. Concannon, D. Greenberg, Joshua T. Cohen +6 more
2013Expert review of pharmacoeconomics & outcomes research19 citations
Semantic Scholar
Costs and Clinical Outcomes among Patients with Second-Line Non-small Cell Lung Cancer in the Outpatient Community Setting
E. Nadler, M. Forsyth, S. Satram-Hoang, C. Reyes
2012Journal of Thoracic Oncology19 citations Open access
Semantic Scholar
Treatment patterns and outcomes among patients with recurrent/metastatic squamous cell carcinoma of the head and neck.
E. Nadler, S. Joo, M. Boyd, J. Black-Shinn +1 more
2019Future Oncology17 citations
Semantic Scholar
Real-world disease burden and outcomes of brain metastases in EGFR mutation-positive non-small-cell lung cancer.
E. Nadler, J. Espirito, M. Pavilack, B. Baidoo +1 more
2020Future Oncology14 citations Open access
Semantic Scholar
How Long and How Well
M. Kozminski, P. Neumann, E. Nadler, A. Janković +1 more
2011Medical decision making14 citations
Semantic Scholar
Clinical Pathways and the Patient Perspective in the Pursuit of Value-Based Oncology Care.
J. Ersek, E. Nadler, J. Freeman-Daily, S. Mazharuddin +1 more
2017American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting13 citations
Semantic Scholar
Quality of survival: a new concept framework to assess the quality of prolonged life in cancer
L. Fallowfield, E. Nadler, I. Gilloteau, M. Greaney +4 more
201713 citations Open access
Semantic Scholar
Biomarker Testing Rates in Patients with Advanced Non-Small Cell Lung Cancer Treated in the Community
E. Nadler, M. Pavilack, J. Clark, J. Espirito +1 more
2019Journal of Cancer Therapy11 citations Open access
Semantic Scholar
Treatment Patterns by EGFR Mutation Status in Non-Small Cell Lung Cancer Patients in the USA: A Retrospective Database Analysis
K. Aguilar, K. Winfree, C. Muehlenbein, Y. Zhu +3 more
2018Advances in Therapy11 citations
Semantic Scholar
Treatment patterns and outcomes in metastatic synovial sarcoma: a real-world study in the US oncology network.
S. Pokras, Wan-Yu Tseng, J. Espirito, A. Beeks +2 more
2022Future Oncology9 citations Open access
Semantic Scholar
Clinical Pathways and the Patient Perspective in the Pursuit of Value-Based Oncology Care.
J. Ersek, E. Nadler, J. Freeman-Daily, S. Mazharuddin +1 more
2017American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting8 citations
Semantic Scholar
Real-world study of patients with locally advanced HNSCC in the community oncology setting
C. Black, K. Ramakrishnan, E. Nadler, Wan-Yu Tseng +6 more
2023Frontiers in Oncology6 citations Open access
Semantic Scholar
Denosumab (AMG 162), a Fully Human Monoclonal Antibody Against RANK Ligand Activity.
G. Reddy, E. Nadler, V. Jain
2005Supportive Cancer Therapy6 citations
Semantic Scholar
Real-world evidence of cancer immunotherapy (CIT) combination treatment in first-line (1L) extensive-stage small cell lung cancer (ES-SCLC).
E. Nadler, A. Vasudevan, K. Davies, Yunfei Wang +2 more
20214 citations
Semantic Scholar
Treatment Patterns and Healthcare Resource Utilization among Patients with Advanced or Metastatic Soft Tissue Sarcoma in US Community Practices
E. Nadler, K. Aguilar, C. Wentworth, M. Boyd +5 more
2020Sarcoma4 citations Open access
Semantic Scholar
How Do Medical and Pharmacy Directors Perceive the Value of New Cancer Drugs
E. Nadler, William C. Broderick, V. Zarotsky, Pharmd +1 more
20094 citations
Semantic Scholar
Current data with HMG-CoA reductase inhibitors (statins) for colorectal cancer prevention.
P. Tyagi, Edward Y. L. Chu, E. Nadler, Vinay Jain
2005Clinical colorectal cancer4 citations
Semantic Scholar
What price for a year of life? A survey of U.S. and Canadian oncologists.
S. Berry, Peter J. Neumann, C. Bell, E. Nadler +4 more
2016Journal of Clinical Oncology3 citations
Semantic Scholar
3331 Quality of survival (QoS) concept framework to assess the quality of prolonged life in advanced melanoma (MEL): Principles and application related to treatment with nivolumab (NIVO)
L. Fallowfield, E. Nadler, A. Abernethy, I. Gilloteau +6 more
20152 citations
Semantic Scholar
Highlights from the International Conference on Molecular Targets and Cancer Therapeutics: Discovery, Biology, And Clinical Applications, Philadelphia, PA, November 2005; ECCO 13--The European Cancer Conference, Paris, France, October 30-November 3, 2005.
Kesava Reddy, A. D'Orazio, E. Nadler, V. Jain
2005Clinical Genitourinary Cancer2 citations
Semantic Scholar
Early clinical data and potential clinical utility of novel histone deacetylase inhibitors in prostate cancer.
G. Reddy, E. Nadler, A. Hussain
2005Clinical Prostate Cancer2 citations
Semantic Scholar
Role of psychostimulants in the management of cancer-related fatigue in patients with advanced cancer.
Kesava Reddy, V. Jain, E. Nadler
2005Supportive Cancer Therapy2 citations
Semantic Scholar
Real-world patterns of biomarker testing and targeted therapy in metastatic non-small cell lung cancer (mNSCLC) in the community oncology setting.
E. Nadler, A. Vasudevan, K. Davies, Yunfei Wang +2 more
20211 citations
Semantic Scholar
Evolution of standard of care therapies used for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): A real-world analysis of patient health records from 2016 to 2019.
N. Saba, S. Shukla, K. Aguilar, M. Ballas +7 more
20211 citations
Semantic Scholar
Outcomes of nivolumab (NIVO)-treated patients (pts) with advanced non-small cell lung cancer (aNSCLC) in United States community oncology practice.
E. Nadler, J. Espirito, Thomas W. Wilson, K. Gupte-Singh +2 more
2019Journal of Clinical Oncology1 citations
Semantic Scholar
MA08.06 Outcomes Among Patients with EGFR-Mutant Metastatic NSCLC with and without Brain Metastases
E. Nadler, M. Pavilack, J. Espirito, B. Baidoo +1 more
2018Journal of Thoracic Oncology1 citations Open access
Semantic Scholar
The Quality of Survival (QoS): A concept framework to assist communication and decision making about cancer care.
L. Fallowfield, E. Nadler, M. Greaney, A. Gater +3 more
2016Journal of Clinical Oncology1 citations
Semantic Scholar
A survey of U.S. and Canadian oncologists' attitudes toward the cost, cost-effectiveness (CE), and reimbursement of cancer drugs.
Peter J. Neumann, S. Berry, E. Nadler, W. Evans +5 more
2009Journal of Clinical Oncology1 citations
Semantic Scholar
Highlights From: The 4th International Congress on Colorectal Cancer; Aventura, Florida, October 2005
P. Tyagi, David J. Lee, G. Reddy, E. Chu +2 more
20051 citations
Semantic Scholar
Abstract 5876: Treatment patterns among metastatic SS patients in The US Oncology Network
S. Pokras, Wan-Yu Tseng, J. Espirito, A. Beeks +3 more
2022Cancer Research0 citations
Semantic Scholar
454 Real-world treatment patterns among patients with locally advanced head and neck squamous cell carcinoma (LA HNSCC) in a community oncology setting
E. Nadler, C. Black, K. Ramakrishnan, Wan-Yu Tseng +6 more
2022Regular and Young Investigator Award Abstracts0 citations Open access
Semantic Scholar
OL01.01 Real-World Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer (aNSCLC) in the US
E. Nadler, Jane Chang, X. Zhang, K. Aguilar +3 more
20210 citations Open access
Semantic Scholar
P1.16-36 Treatment Patterns Among Patients with EGFRm NSCLC Treated in the US Community Oncology Setting
E. Nadler, M. Pavilack, J. Clark, J. Espirito +1 more
2019Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
Understanding epidermal growth factor receptor mutation (EGFRm) testing in patients (pts) with non-small cell lung cancer (NSCLC) in a large community oncology network.
E. Nadler, Ancilla W. Fernandes, M. Pavilack, Susan Amirian +2 more
2018Journal of Clinical Oncology0 citations
Semantic Scholar
Understanding treatment patterns and outcomes in patients with metastatic NSCLC treated in a US community oncology network.
E. Nadler, J. Espirito, M. Pavilack, M. Boyd +2 more
20170 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Espirito×10
Invite
J. Espirito — researcher profile on SciRah
M. Pavilack×8
Invite
M. Pavilack — researcher profile on SciRah
Ancilla W. Fernandes×8
Invite
Ancilla W. Fernandes — researcher profile on SciRah
P. Neumann×6
Invite
P. Neumann — researcher profile on SciRah

×6

Invite

Wan-Yu Tseng — researcher profile on SciRah

Invite

P. Ubel — researcher profile on SciRah

Invite

M. Boyd — researcher profile on SciRah

Invite

J. Palmer — researcher profile on SciRah

Invite

S. Berry — researcher profile on SciRah

Invite

C. Bell — researcher profile on SciRah

Invite

K. Aguilar — researcher profile on SciRah

Invite

J. Clark — researcher profile on SciRah